In subgroup analyses, the transcriptomic profile of responders (vs. current MDD) shows inhibition of immune pathways independently of CRP levels, while the inhibition of cell-cycle-related pathways in MDD with CRP < 1 mg/L is present only in those who are currently depressed. The gene discussed is CRP; the disease is major depressive disorder.